Information  X 
Enter a valid email address

NMC Health Plc (NMC)

  Print      Mail a friend       Annual reports

Friday 15 March, 2019

NMC Health Plc

Grant of Options

RNS Number : 0675T
NMC Health Plc
15 March 2019
 

 

NMC Health plc

 

Grant of options

 

London, 15 March 2019: NMC Health plc ("NMC", the "Company" or the "Group"), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, announces that on 15 March 2019 it granted awards over a total of 119,674 Ordinary shares under its Deferred Share Bonus Plan.

 

These awards, by way of nil-cost options, were made to Directors and PDMRs of the Company as follows:

 

Name of individual

Director / PDMR

Number of Shares subject to award

Prasanth Manghat

Director

39,160

Khalifa Bin Butti

Director

22,735

Hani Buttikhi

Director

18,496

Prasanth Shenoy

PDMR

14,859

Michael Davis

PDMR

11,608

Dr. Chandrakumari Shetty

PDMR

12,816

 

Under the terms of the Company's Short-Term Incentive Plan, two-thirds of any earned bonus is to be provided in the form of a share award which provides that such shares are only released to participants after a deferral period of one-year in relation to 50% of the share award and two-years in relation to the remaining 50% of the award.

 

The DSBP is the plan which the Company is operating to deliver such deferred shares to scheme participants. The above award is in relation to the bonus earned pursuant to the 2018 Short Term Incentive Plan.  

 

This notification is made in accordance with the Market Abuse Regulation.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mr Prasanth Manghat

Mr Khalifa Bin Butti

Mr Hani Buttikhi

Mr Prashanth Shenoy

Mr Michael Davis

Dr Chandrakumari Shetty

2

Reason for the notification

a)

Position/status

Directors and PDMRs of the Company

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NMC Health plc

b)

LEI

2138008YQEVWBE1V2M52

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares

 

 

ISIN: GB00B7FC0762

 

b)

Nature of the transaction

Grant of nil-cost options

 

c)

Price(s) and volume(s)

 Price

No. of shares

0p

39,160

0p

22,735

0p

18,496

0p

14,859

0p

11,608

0p

12,816

d)

Aggregated information

- volume

- Price

- Total

N/A

 

 

 

e)

Date of the transaction

15 March 2019

f)

Place of the transaction

Not on a trading venue

 

Contacts

Investors

 

 

NMC

 

Simon Watkins, Group Company Secretary

+44 (0)20 3205 7313

 

 

Media

 

FTI Consulting, London

 

Brett Pollard

+44 (0)20 3727 1000

 

 

FTI Consulting, Gulf

 

Shane Dolan

+971 (0)4 437 2100  

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHJAMITMBIBBAL

a d v e r t i s e m e n t